A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine
Clinical trial NCT06619509 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06619509
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2030-12-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.